Schonfeld Strategic Advisors LLC
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 1665241
NEW YORK, NY
Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,882,584
+$18,374,607 QoQ
Shares Held
324,722
+2466.6% QoQ
Ownership
0.336%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $295,816,121 across 125 Biotechnology names. XENE ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,757,899 | $25,419,219 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
71,767 | $23,745,547 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
318,405 | $21,692,932 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
324,722 | $18,882,584 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
254,827 | $17,132,019 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
62,142 | $11,747,945 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
494,737 | $10,364,740 | |
| 8 | INSM |
INSMED Inc
|
56,056 | $9,166,277 |
All Filings in XENE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,882,584 | 324,722 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $507,977 | 12,652 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $329,839 | 10,538 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $770,106 | 22,954 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $593,880 | 15,150 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $534,723 | 13,582 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,257,817 | 32,260 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,441,890 | 79,951 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,030,250 | 87,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,797,293 | 198,984 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,935,505 | 180,143 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,741,259 | 300,119 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,640,524 | 168,413 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,909,052 | 108,284 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,897,075 | 128,109 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,129,573 | 102,374 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,777,236 | 88,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,835,448 | 120,121 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,798,692 | 96,600 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $1,492,860 | 83,400 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,116,588 | 72,600 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $692,982 | 62,600 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $446,424 | 35,600 | Shares | Sole | 2020-09-15 | |
| 2020-03-31 | $147,420 | 13,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||